Document is current
Any future updates will be listed below
-
Authors
Li, Junwei
Hu, Kai
Fan, Xueru
Wang, Sisheng
He, Tao
Xu, Caiyun
Cai, Qiwen
Chen, Jinyan
Ling, Yating
Yang, Jianmin
Fan, Xiaohui
Kong, Dexing
Zhang, Lixia
Li, Lu
-
Funding
Funding for this research was provided by:
The High-level Talents Special Support Program of Zhejiang Province (2024-KYY-GXJS-0026)
National Key Research and Development Program of China (2023YFC3504600)
Transverse Research Project of Zhejiang University (2023-KYY-A070350007)
National Natural Science Foundation of Zhejiang Province (LY20H180004)
The Zhejiang Province Traditional Chinese Medicine Science and Technology Project (GZY-ZJKJ-24076)
- License Information
-
More Information
Article History
Received: 9 February 2025
Accepted: 2 April 2026
First Online: 14 April 2026
Declarations
:
: The authors declare no competing interests.
: We confirmed that we have read the Editorial Policy pages. This study was conducted with approval from the Ethics Committee of the First Affiliated Hospital of Zhejiang Chinese Medical University on February 8, 2022. (No.2022-KL-008-01). This study was conducted in accordance with the declaration of Helsinki. This study has approved to waive the informed consent from all patients, because in this study, PET/CT images were obtained from PET/CT workstations, all of which were images of ovarian cancer patients who had undergone PET/CT examination. This study only analyzed the imaging features and texture of PET/CT images of ovarian cancer patients, and did not involve patient identity information. The images were limited to this study and were not used for other purposes. All PET/CT patients sign informed consent prior to the examination, giving consent for the images to be used for scientific research, as mentioned in the attached files.
